HuGE Literature Finder
Records
1
-
26
| Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. British journal of clinical pharmacology 2023 1 . Nyangwara Vincent Aketch, Mazhindu Tinashe, Chikwambi Zedias, Masimirembwa Collen, Campbell Thomas B, Borok Margaret, Ndlovu Ntoko |
| Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study. JMIR research protocols 2022 2 11 (2): e27898. Zolk Oliver, von dem Knesebeck Annika, Graf Norbert, Simon Thorsten, Hero Barbara, Abdul-Khaliq Hashim, Abd El Rahman Mohamed, Spix Claudia, Mayer Benjamin, Elsner Susanne, Gebauer Judith, Langer Thorst |
| Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Molecular and cellular biochemistry 2022 12 . Matsumoto Jun, Nishimoto Anzu, Watari Shogo, Ueki Hideo, Shiromizu Shoya, Iwata Naohiro, Takeda Tatsuaki, Ushio Soichiro, Kajizono Makoto, Fujiyoshi Masachika, Koyama Toshihiro, Araki Motoo, Wada Koichiro, Zamami Yoshito, Nasu Yasutomo, Ariyoshi Norita |
| Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Pathology, research and practice 2018 Apr . Xie Zu-Cheng, Li Tian-Tian, Gan Bin-Liang, Gao Xiang, Gao Li, Chen Gang, Hu Xiao-H |
| Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations. PloS one 2018 13 (2): e0192223. Sheth Harsh, Northwood Emma, Ulrich Cornelia M, Scherer Dominique, Elliott Faye, Barrett Jennifer H, Forman David, Wolf C Roland, Smith Gillian, Jackson Michael S, Santibanez-Koref Mauro, Haile Robert, Casey Graham, Jenkins Mark, Win Aung Ko, Hopper John L, Marchand Loic Le, Lindor Noralane M, Thibodeau Stephen N, Potter John D, Burn John, Bishop D Timot |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2017 Dec . Tang Li, Platek Mary E, Yao Song, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Wu Yue, Platz Elizabeth A, Neuhouser Marian L, Stanczyk Frank Z, Reichardt Juergen K V, Santella Regina M, Hsing Ann, Figg William D, Lippman Scott M, Thompson Ian M, Ambrosone Christine |
| Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study. BMC cancer 2017 Dec 17 (1): 901. Falkowski Sabrina, Woillard Jean-Baptiste, Postil Deborah, Tubiana-Mathieu Nicole, Terrebonne Eric, Pariente Antoine, Smith Denis, Guimbaud Rosine, Thalamas Claire, Rouguieg-Malki Koukeb, Marquet Pierre, Picard Nicol |
| Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). British journal of cancer 2017 Aug . Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet |
| The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy. Endocrine-related cancer 2015 Feb 22 (1): 77-85. Laverdière Isabelle, Flageole Christine, Audet-Walsh Étienne, Caron Patrick, Fradet Yves, Lacombe Louis, Lévesque Éric, Guillemette Chant |
| Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry. Genes, chromosomes & cancer 2014 Jul 53 (7): 568-78. Scherer Dominique, Koepl Lisel M, Poole Elizabeth M, Balavarca Yesilda, Xiao Liren, Baron John A, Hsu Li, Coghill Anna E, Campbell Peter T, Kleinstein Sarah E, Figueiredo Jane C, Lampe Johanna W, Buck Katharina, Potter John D, Kulmacz Richard J, Jenkins Mark A, Hopper John L, Win Aung K, Newcomb Polly A, Ulrich Cornelia M, Makar Karen |
| S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. British journal of cancer 2013 Sep 109 (6): 1420-7. Kim S Y, S Hong Y, K Shim E, Kong S-Y, Shin A, Baek J Y, Jung K |
| Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head & neck 2013 Jun 35 (6): 858-67. Lacko Martin, Voogd Adri C, Roelofs Hennie M J, te Morsche Rene H M, Oude Ophuis Michel B, Peters Wilbert H M, Manni Johannes |
| Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer research 2013 Apr 73 (7): 2211-20. Garcia-Closas Montserrat, Rothman Nathaniel, Figueroa Jonine D, Prokunina-Olsson Ludmila, Han Summer S, Baris Dalsu, Jacobs Eric J, Malats Nuria, De Vivo Immaculata, Albanes Demetrius, Purdue Mark P, Sharma Sapna, Fu Yi-Ping, Kogevinas Manolis, Wang Zhaoming, Tang Wei, Tardón Adonina, Serra Consol, Carrato Alfredo, García-Closas Reina, Lloreta Josep, Johnson Alison, Schwenn Molly, Karagas Margaret R, Schned Alan, Andriole Gerald, Grubb Robert, Black Amanda, Gapstur Susan M, Thun Michael, Diver William Ryan, Weinstein Stephanie J, Virtamo Jarmo, Hunter David J, Caporaso Neil, Landi Maria Teresa, Hutchinson Amy, Burdett Laurie, Jacobs Kevin B, Yeager Meredith, Fraumeni Joseph F, Chanock Stephen J, Silverman Debra T, Chatterjee Nilanj |
| Red meat and poultry, cooking practices, genetic susceptibility and risk of prostate cancer: results from a multiethnic case-control study. Carcinogenesis 2012 Nov 33 (11): 2108-18. Joshi Amit D, Corral Román, Catsburg Chelsea, Lewinger Juan Pablo, Koo Jocelyn, John Esther M, Ingles Sue A, Stern Mariana |
| Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Human molecular genetics 2012 Apr 21 (8): 1918-30. Tang Wei, Fu Yi-Ping, Figueroa Jonine D, Malats Núria, Garcia-Closas Montserrat, Chatterjee Nilanjan, Kogevinas Manolis, Baris Dalsu, Thun Michael, Hall Jennifer L, De Vivo Immaculata, Albanes Demetrius, Porter-Gill Patricia, Purdue Mark P, Burdett Laurie, Liu Luyang, Hutchinson Amy, Myers Timothy, Tardón Adonina, Serra Consol, Carrato Alfredo, Garcia-Closas Reina, Lloreta Josep, Johnson Alison, Schwenn Molly, Karagas Margaret R, Schned Alan, Black Amanda, Jacobs Eric J, Diver W Ryan, Gapstur Susan M, Virtamo Jarmo, Hunter David J, Fraumeni Joseph F, Chanock Stephen J, Silverman Debra T, Rothman Nathaniel, Prokunina-Olsson Ludmi |
| Association between polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and colorectal cancer risk. Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2311-4. Osawa Kayo, Nakarai Chiaki, Akiyama Minami, Hashimoto Ryuta, Tsutou Akimitsu, Takahashi Juro, Takaoka Yuko, Kawamura Shiro, Shimada Etsuji, Tanaka Kenichi, Kozuka Masaya, Yamamoto Masahiro, Kido Yoshia |
| UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population. PloS one 2012 7 (8): e42873. Kua Ley-Fang, Ross Soo, Lee Soo-Chin, Mimura Kousaku, Kono Koji, Goh Boon-Cher, Yong Wei-Pe |
| Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Apr 22 (4): 890-6. Park S R, Kong S-Y, Rhee J, Park Y-I, Ryu K W, Lee J H, Kim Y-W, Choi I J, Kim C G, Lee J Y, Cho S-J, Kim N |
| Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk. Breast cancer research and treatment 2010 Nov 124 (1): 289-92. Justenhoven Christina, Winter Stefan, Dünnebier Thomas, Hamann Ute, Baisch Christian, Rabstein Sylvia, Spickenheuer Anne, Harth Volker, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Brauch Hiltr |
| Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast cancer research and treatment 2010 Jan 119 (2): 463-74. Authors are not available |
| No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World journal of gastroenterology : WJG 2009 May 15 (18): 2240-4. Thompson Cheryl-L, Plummer Sarah-J, Merkulova Alona, Cheng Iona, Tucker Thomas-C, Casey Graham, Li |
| Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients. Therapeutic drug monitoring 2008 Oct 30 (5): 559-64. Miura Masatomo, Kagaya Hideaki, Satoh Shigeru, Inoue Kazuyuki, Saito Mitsuru, Habuchi Tomonori, Suzuki Tosh |
| Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006 Jul 4 (7): 894-901. Samowitz Wade S, Wolff Roger K, Curtin Karen, Sweeney Carol, Ma Khe-Ni, Andersen Kristen, Levin Theodore R, Slattery Martha |
| UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Feb 11 (3): 1226-36. Carlini Leslie E, Meropol Neal J, Bever John, Andria Michael L, Hill Todd, Gold Philip, Rogatko Andre, Wang Hao, Blanchard Rebecca |
| Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004 Dec 25 (12): 2407-15. van der Logt E M J, Bergevoet S M, Roelofs H M J, van Hooijdonk Z, te Morsche R H M, Wobbes T, de Kok J B, Nagengast F M, Peters W H |
| CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer research 2001 May 61 (9): 3566-9. Bigler J, Whitton J, Lampe J W, Fosdick L, Bostick R M, Potter J |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: